Scarica l'app Stockscreener
145.27
1.34%
-1.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$147.24
Aprire:
$145.02
Volume 24 ore:
8.38M
Relative Volume:
0.78
Capitalizzazione di mercato:
$358.41B
Reddito:
$65.51B
Utile/perdita netta:
$8.93B
Rapporto P/E:
40.88
EPS:
3.5532
Flusso di cassa netto:
$14.12B
1 W Prestazione:
-0.47%
1M Prestazione:
-1.90%
6M Prestazione:
+26.74%
1 anno Prestazione:
+66.63%
Intervallo 1D:
$143.41
$145.44
Intervallo di 1 settimana:
$143.41
$154.02
Portata 52W:
$82.01
$156.92
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
145.27 | 358.41B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,273.46 | 1.14T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
263.81 | 635.07B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
285.64 | 504.76B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
151.12 | 287.24B | 54.66B | 13.58B | 16.05B | 7.0171 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-08-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-08-12 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2026-05-06 | Ripresa | Citigroup | Neutral |
| 2026-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-02-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Why Healthcare ETFs Are Hovering Around One-Year Highs - Zacks Investment Research
Moderna, Merck Shares Fall After Possible Melanoma Data Leak - Bloomberg.com
Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports - The Motley Fool
Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat - Reuters
Merck & Co Inc Stock (MRK) Moved Down by 3.28% on Oct 22: A Full Analysis - TradingKey
Summit Expands Ivonescimab Development Into Biliary Tract Cancer - Zacks Investment Research
Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline - Zacks Investment Research
6,761 Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat
Merck & Co., Inc. $MRK Stock Sold by Inlet Private Wealth LLC - MarketBeat
Merck & Co., Inc. $MRK Stock Sold by Crossmark Global Holdings Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Diversify Advisory Services LLC - MarketBeat
Merck & Co., Inc. (MRK) Set to Release Earnings on Thursday - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lowered by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat
27,739 Merck & Co., Inc. $MRK Shares Sold by Axxcess Wealth Management LLC - MarketBeat
Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsight - GlobeNewswire Inc.
Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 - The Motley Fool
Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio? - Zacks Investment Research
Merck & Co., Inc. (NYSE:MRK) Cut to "Strong Sell" at Zacks Research - MarketBeat
6,860 Merck & Co., Inc. $MRK Shares Sold by QV Investors Inc. - MarketBeat
119,254 Merck & Co., Inc. $MRK Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Merck & Co., Inc. $MRK Stock Sold by Nisa Investment Advisors LLC - MarketBeat
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice - The Motley Fool
Bank Pictet & Cie Europe AG Sells 42,242 Shares of Merck & Co., Inc. $MRK - MarketBeat
Why Are Market Participants Following Merck & Co. (NYSE:MRK)? - Kalkine Media
Lobbying Update: $2,390,000 of MERCK & CO INC lobbying was just disclosed - Quiver Quantitative
Is Merck & Co Inc (MRK) Overvalued After 3.2% Rally? GF Value Sa - GuruFocus
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million - GlobeNewswire Inc.
Net current asset value per share of Merck & Co., Inc. Shs Thailand Depositary Receipts Repr 1 Sh – SET:MRK03 - TradingView
Catholic Medical Mission Board and Church of the Brethren to mark partnership with ribbon-cutting - GlobeNewswire Inc.
Merck & Co., Inc. $MRK Stock: Willis Investment Counsel Cuts Holdings - MarketBeat
Merck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff? - Yahoo Finance
Merck Discontinues Bacterial Infection Drug in Europe - Benzinga
Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send? - TradingKey
GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth - Zacks Investment Research
Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings - ChartMill
64,996 Merck & Co., Inc. $MRK Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Merck’s 2.4% Dividend Yield: A Reliable Income Stream or a Risky Bet on Recovery? - Yahoo Finance
Merck & Co., Inc. $MRK Position Boosted by Fairvoy Private Wealth LLC - MarketBeat
Merck (MRK) Stock Dips While Market Gains: Key Facts - Zacks Investment Research
13,487 Merck & Co., Inc. $MRK Shares Sold by Generali Investments Management Co LLC - MarketBeat
MERCK & CO INC : HSBC RAISES TARGET PRICE TO $175 FROM $172 - Moomoo
Merck & Company, Inc. (MRK) Stock Forecasts - Yahoo Finance
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. - The Motley Fool
Merck & Co., Inc. $MRK Stock: Birch Hill Investment Advisors LLC Cuts Holdings - MarketBeat
Merck & Co., Inc. $MRK Stock: 1834 Investment Advisors Co. Decreases Position - MarketBeat
Merck & Co., Inc. $MRK Stock: Hengehold Capital Management LLC Reduces Position - MarketBeat
TD Waterhouse Canada Inc. Purchases 131,302 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock: Cantor Fitzgerald Investment Advisors L.P. Cuts Position - MarketBeat
Merck & Co., Inc. $MRK Stock: Banque Pictet & Cie SA Cuts Holdings - MarketBeat
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Merck Co Inc Azioni (MRK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| CHIRFI GUINDO | Officer |
Aug 13 '26 |
Proposed Sale |
135.00 |
10,000 |
1,350,000 |
0 |
| JENNIFER L ZACHARY | Officer |
Aug 12 '26 |
Proposed Sale |
133.46 |
80,315 |
10,718,495 |
0 |
| RICHARD ROBERT DELUCA JR | Officer |
Aug 12 '26 |
Proposed Sale |
131.63 |
11,699 |
1,539,992 |
0 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth |
Aug 12 '26 |
Sale |
131.63 |
11,699 |
1,539,992 |
110,167 |
| Zachary Jennifer | EVP, General Counsel |
Aug 12 '26 |
Option Exercise |
109.78 |
54,927 |
6,029,637 |
125,824 |
| Zachary Jennifer | EVP, General Counsel |
Aug 12 '26 |
Sale |
133.46 |
80,315 |
10,718,495 |
45,509 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth |
Aug 11 '26 |
Sale |
131.76 |
12,837 |
1,691,426 |
121,866 |
| RICHARD ROBERT DELUCA JR | Officer |
Aug 11 '26 |
Proposed Sale |
131.76 |
12,837 |
1,691,426 |
0 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth |
Aug 10 '26 |
Sale |
130.43 |
20,784 |
2,710,951 |
134,703 |
| RICHARD ROBERT DELUCA JR | Officer |
Aug 10 '26 |
Proposed Sale |
130.43 |
20,784 |
2,710,951 |
0 |
3.30%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):